Literature DB >> 17200883

Effect of nicking the C-terminal region of the Clostridium botulinum serotype D neurotoxin heavy chain on its toxicity and molecular properties.

Tomonori Suzuki1, Hirokazu Kouguchi, Toshihiro Watanabe, Kimiko Hasegawa, Tohru Yoneyama, Koichi Niwa, Atsushi Nishikawa, Jae-Chul Lee, Keiji Oguma, Tohru Ohyama.   

Abstract

A unique strain of Clostridium botulinum serotype D 4947 produces toxin complexes that are composed of un-nicked components, including a neurotoxin (BoNT) and auxiliary proteins. This BoNT showed aberrant elution upon Superdex gel filtration, indicating a much lower molecular weight, due to hydrophobic interaction with the column. Limited trypsin proteolysis of BoNT produces two nicks; first nick yielded a BoNT 50 kDa light chain disulfide linked to a 100 kDa heavy chain (Hc), and a second nick arose in Hc C-terminal 10 kDa. The second nick occurred in the putative binding domain of the BoNT molecule and induced alterations in its secondary structure, leading to a significant reduction of mouse toxicity in comparison with that of the fully-activated singly nicked BoNT. These results help to clarify the role of the C-terminal half of the Hc in the oral toxicity of single-chain and more complex forms of BoNT.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17200883     DOI: 10.1007/s10930-006-9059-7

Source DB:  PubMed          Journal:  Protein J        ISSN: 1572-3887            Impact factor:   4.000


  34 in total

1.  Crystallization and preliminary X-ray analysis of Clostridium botulinum neurotoxin type B.

Authors:  S Swaminathan; S Eswaramoorthy
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2000-08

2.  Spontaneous nicking in the nontoxic-nonhemagglutinin component of the Clostridium botulinum toxin complex.

Authors:  Yoshimasa Sagane; Toshihiro Watanabe; Hirokazu Kouguchi; Hiroyuki Sunagawa; Shigehiro Obata; Keiji Oguma; Tohru Ohyama
Journal:  Biochem Biophys Res Commun       Date:  2002-03-29       Impact factor: 3.575

3.  Crystal structure of botulinum neurotoxin type A and implications for toxicity.

Authors:  D B Lacy; W Tepp; A C Cohen; B R DasGupta; R C Stevens
Journal:  Nat Struct Biol       Date:  1998-10

4.  The binding of botulinum toxin to membrane lipids: sphingolipids, steroids and fatty acids.

Authors:  L L Simpson; M M Rapport
Journal:  J Neurochem       Date:  1971-09       Impact factor: 5.372

5.  Isolation and molecular size of Clostridium botulinum type C toxin.

Authors:  B Syuto; S Kubo
Journal:  Appl Environ Microbiol       Date:  1977-02       Impact factor: 4.792

6.  Molecular composition of progenitor toxin produced by Clostridium botulinum type C strain 6813.

Authors:  T Watanabe; Y Sagane; H Kouguchi; H Sunagawa; K Inoue; Y Fujinaga; K Oguma; T Ohyama
Journal:  J Protein Chem       Date:  1999-10

7.  Characterization of nontoxic-nonhemagglutinin component of the two types of progenitor toxin (M and L) produced by Clostridium botulinum type D CB-16.

Authors:  T Ohyama; T Watanabe; Y Fujinaga; K Inoue; H Sunagawa; N Fujii; K Inoue; K Oguma
Journal:  Microbiol Immunol       Date:  1995       Impact factor: 1.955

8.  Molecular cloning of the gene encoding the mosaic neurotoxin, composed of parts of botulinum neurotoxin types C1 and D, and PCR detection of this gene from Clostridium botulinum type C organisms.

Authors:  K Moriishi; M Koura; N Fujii; Y Fujinaga; K Inoue; B Syuto; K Oguma
Journal:  Appl Environ Microbiol       Date:  1996-02       Impact factor: 4.792

9.  Botulinum neurotoxin A activity is dependent upon the presence of specific gangliosides in neuroblastoma cells expressing synaptotagmin I.

Authors:  Brian C Yowler; Richard D Kensinger; Cara-Lynne Schengrund
Journal:  J Biol Chem       Date:  2002-06-27       Impact factor: 5.157

Review 10.  Neurotoxins affecting neuroexocytosis.

Authors:  G Schiavo; M Matteoli; C Montecucco
Journal:  Physiol Rev       Date:  2000-04       Impact factor: 37.312

View more
  1 in total

1.  Purification and characterization of nontoxic protein complex from serotype D 4947 botulinum toxin complex.

Authors:  Keita Miyata; Yoshimasa Sagane; Ken Inui; Shin-Ichiro Miyashita; Tomonori Suzuki; Keiji Oguma; Tohru Ohyama; Koichi Niwa; Toshihiro Watanabe
Journal:  Protein J       Date:  2012-06       Impact factor: 2.371

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.